Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 EUR | +5.13% | -6.18% | -20.33% |
05-21 | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
05-15 | Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.33% | 37.45M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.75% | 22.1B | |
-9.14% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- Medigene AG Provides Earnings Guidance for the Year 2021